SU921467A3 - Способ получени производных морфина - Google Patents
Способ получени производных морфина Download PDFInfo
- Publication number
- SU921467A3 SU921467A3 SU782595556A SU2595556A SU921467A3 SU 921467 A3 SU921467 A3 SU 921467A3 SU 782595556 A SU782595556 A SU 782595556A SU 2595556 A SU2595556 A SU 2595556A SU 921467 A3 SU921467 A3 SU 921467A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- carbon atoms
- alkyl
- hydrogen atom
- general formula
- cycloalkyl
- Prior art date
Links
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical class O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 15
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 claims description 8
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims description 3
- 125000003118 aryl group Chemical group 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229960005181 morphine Drugs 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940126601 medicinal product Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000556 agonist Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000003533 narcotic effect Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZENNIHDHUIWZRA-SEJAZBPASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC ZENNIHDHUIWZRA-SEJAZBPASA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- LKBREHQHCVRNFR-UHFFFAOYSA-K [B+3].[Br-].[Br-].[Br-] Chemical compound [B+3].[Br-].[Br-].[Br-] LKBREHQHCVRNFR-UHFFFAOYSA-K 0.000 description 1
- IUHFWCGCSVTMPG-UHFFFAOYSA-N [C].[C] Chemical group [C].[C] IUHFWCGCSVTMPG-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001270 agonistic effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000020335 dealkylation Effects 0.000 description 1
- 238000006900 dealkylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB12325/77A GB1593191A (en) | 1977-03-23 | 1977-03-23 | Derivatives of morphine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU921467A3 true SU921467A3 (ru) | 1982-04-15 |
Family
ID=10002423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU782595556A SU921467A3 (ru) | 1977-03-23 | 1978-03-21 | Способ получени производных морфина |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4241066A (enExample) |
| JP (1) | JPS53119899A (enExample) |
| AT (1) | AT361139B (enExample) |
| AU (1) | AU519643B2 (enExample) |
| BE (1) | BE865183A (enExample) |
| CA (1) | CA1089456A (enExample) |
| CH (1) | CH629809A5 (enExample) |
| CS (1) | CS200542B2 (enExample) |
| DD (1) | DD133950A5 (enExample) |
| DE (1) | DE2812580A1 (enExample) |
| DK (1) | DK149858C (enExample) |
| ES (1) | ES468173A1 (enExample) |
| FI (1) | FI68236C (enExample) |
| FR (1) | FR2384774A1 (enExample) |
| GB (1) | GB1593191A (enExample) |
| IE (1) | IE46443B1 (enExample) |
| IT (1) | IT1105176B (enExample) |
| LU (1) | LU79294A1 (enExample) |
| NL (1) | NL7803083A (enExample) |
| NZ (1) | NZ186692A (enExample) |
| PL (1) | PL114723B1 (enExample) |
| SE (1) | SE436131B (enExample) |
| SU (1) | SU921467A3 (enExample) |
| ZA (1) | ZA781527B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4362870A (en) * | 1980-01-16 | 1982-12-07 | Regents Of The University Of Minnesota | Selective opioid receptor alkylating agents |
| US4401672A (en) * | 1981-10-13 | 1983-08-30 | Regents Of The University Of Minnesota | Non-addictive narcotic antitussive preparation |
| JPS59500418A (ja) * | 1982-03-16 | 1984-03-15 | ザ ロツクフエラ− ユニバ−シテイ | 胃腸能動作用障害を回復する方法 |
| GB8711558D0 (en) * | 1987-05-15 | 1987-06-17 | Reckitt & Colmann Prod Ltd | Derivative of codeine |
| EP0846694A1 (en) * | 1992-01-23 | 1998-06-10 | Toray Industries, Inc. | Morphinan derivative and its pharmaceutical applications |
| IT1269826B (it) * | 1994-05-24 | 1997-04-15 | Paolo Minoia | Uso di antagonisti degli oppiacei e di sali di calcio per la preparazione di medicamenti per il trattamento di forme patologiche endorfino-mediate |
| BRPI0409133B8 (pt) | 2003-04-08 | 2021-05-25 | Progenics Pharm Inc | preparações farmacêuticas estavéis compreendendo metilnaltrexona |
| US20060063792A1 (en) * | 2004-09-17 | 2006-03-23 | Adolor Corporation | Substituted morphinans and methods of their use |
| AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
| AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
| DE602006019246D1 (de) | 2005-06-16 | 2011-02-10 | Mallinckrodt Inc | Synthetische route zu 14-hydroxylopiaten über 1-halogenthebain oder analoga |
| WO2007124114A2 (en) * | 2006-04-21 | 2007-11-01 | Nektar Therapeutics Al, Corporation | Stereoselective reduction of a morphinone |
| TWI489984B (zh) | 2006-08-04 | 2015-07-01 | Wyeth Corp | 用於非經腸道傳輸化合物之配方及其用途 |
| PT2139890E (pt) | 2007-03-29 | 2014-09-03 | Wyeth Llc | Antagonistas do receptor opióide periférico e respectivas utilizações |
| CA2682125C (en) | 2007-03-29 | 2015-06-16 | Progenics Pharmaceuticals, Inc. | Peripheral opioid receptor antagonists and uses thereof |
| EP2134718A2 (en) | 2007-03-29 | 2009-12-23 | Progenics Pharmaceuticals, Inc. | Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof |
| CA2713568C (en) | 2008-02-06 | 2016-09-20 | Progenics Pharmaceuticals, Inc. | Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
| AU2009300390B2 (en) | 2008-09-30 | 2015-05-14 | SpecGx LLC | Processes for the production of buprenorphine with reduced impurity formation |
| EP2342207B1 (en) | 2008-09-30 | 2015-11-11 | Mallinckrodt LLC | Processes for the alkylation of norbuprenorphine with reduced impurity formation |
| CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
| EP3077398B1 (en) | 2013-12-05 | 2020-03-11 | The University of Bath | Novel opioid compounds and their uses |
| CN110330500B (zh) * | 2019-07-12 | 2021-11-23 | 宜昌人福药业有限责任公司 | 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3322771A (en) * | 1967-05-30 | Intermediates for preparing thebaine derivatives | ||
| US3332950A (en) * | 1963-03-23 | 1967-07-25 | Endo Lab | 14-hydroxydihydronormorphinone derivatives |
| IL26896A (en) * | 1966-01-19 | 1970-11-30 | Endo Lab | 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones |
| BE788478A (fr) * | 1971-09-08 | 1973-03-06 | Bristol Myers Co | Procede de preparation de composes analgesiques |
| US4017497A (en) * | 1975-11-18 | 1977-04-12 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinan derivatives |
| US4089855A (en) * | 1976-04-23 | 1978-05-16 | Cornell Research Foundation, Inc. | Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby |
-
1977
- 1977-03-23 GB GB12325/77A patent/GB1593191A/en not_active Expired
-
1978
- 1978-03-14 IE IE515/78A patent/IE46443B1/en unknown
- 1978-03-14 NZ NZ186692A patent/NZ186692A/xx unknown
- 1978-03-15 US US05/886,833 patent/US4241066A/en not_active Expired - Lifetime
- 1978-03-15 ZA ZA00781527A patent/ZA781527B/xx unknown
- 1978-03-21 AU AU34357/78A patent/AU519643B2/en not_active Expired
- 1978-03-21 SU SU782595556A patent/SU921467A3/ru active
- 1978-03-21 FI FI780882A patent/FI68236C/fi not_active IP Right Cessation
- 1978-03-22 BE BE186174A patent/BE865183A/xx not_active IP Right Cessation
- 1978-03-22 CA CA299,532A patent/CA1089456A/en not_active Expired
- 1978-03-22 IT IT48544/78A patent/IT1105176B/it active
- 1978-03-22 NL NL7803083A patent/NL7803083A/xx not_active Application Discontinuation
- 1978-03-22 SE SE7803328A patent/SE436131B/sv not_active IP Right Cessation
- 1978-03-22 DK DK130078A patent/DK149858C/da not_active IP Right Cessation
- 1978-03-22 DE DE19782812580 patent/DE2812580A1/de not_active Ceased
- 1978-03-22 CS CS781846A patent/CS200542B2/cs unknown
- 1978-03-22 ES ES468173A patent/ES468173A1/es not_active Expired
- 1978-03-22 PL PL1978205498A patent/PL114723B1/pl unknown
- 1978-03-22 LU LU79294A patent/LU79294A1/xx unknown
- 1978-03-22 CH CH316078A patent/CH629809A5/fr not_active IP Right Cessation
- 1978-03-22 FR FR7808404A patent/FR2384774A1/fr active Granted
- 1978-03-22 JP JP3354678A patent/JPS53119899A/ja active Granted
- 1978-03-22 AT AT204278A patent/AT361139B/de not_active IP Right Cessation
- 1978-03-22 DD DD78204349A patent/DD133950A5/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0112755B2 (enExample) | 1989-03-02 |
| FI68236B (fi) | 1985-04-30 |
| PL205498A1 (pl) | 1979-04-09 |
| IT1105176B (it) | 1985-10-28 |
| GB1593191A (en) | 1981-07-15 |
| FR2384774A1 (fr) | 1978-10-20 |
| SE436131B (sv) | 1984-11-12 |
| NL7803083A (nl) | 1978-09-26 |
| IE46443B1 (en) | 1983-06-15 |
| DK149858C (da) | 1987-06-29 |
| IT7848544A0 (it) | 1978-03-22 |
| ES468173A1 (es) | 1979-09-16 |
| DK130078A (da) | 1978-09-24 |
| NZ186692A (en) | 1980-02-21 |
| JPS53119899A (en) | 1978-10-19 |
| PL114723B1 (en) | 1981-02-28 |
| BE865183A (fr) | 1978-09-22 |
| DK149858B (da) | 1986-10-13 |
| LU79294A1 (fr) | 1979-10-29 |
| FI780882A7 (fi) | 1978-09-24 |
| CH629809A5 (fr) | 1982-05-14 |
| CS200542B2 (en) | 1980-09-15 |
| DE2812580A1 (de) | 1978-10-05 |
| CA1089456A (en) | 1980-11-11 |
| ATA204278A (de) | 1980-07-15 |
| AU3435778A (en) | 1979-09-27 |
| US4241066A (en) | 1980-12-23 |
| AT361139B (de) | 1981-02-25 |
| IE780515L (en) | 1978-09-23 |
| DD133950A5 (de) | 1979-01-31 |
| FR2384774B1 (enExample) | 1981-10-16 |
| ZA781527B (en) | 1979-04-25 |
| SE7803328L (sv) | 1978-09-24 |
| FI68236C (fi) | 1985-08-12 |
| AU519643B2 (en) | 1981-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU921467A3 (ru) | Способ получени производных морфина | |
| NO154883B (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-acylaminomethyl-1,4-benzodiazepiner. | |
| JPS61271275A (ja) | モルヒナン誘導体 | |
| DE2062001C2 (de) | 1,2,3,4-Tetrahydro-4-phenylisochinolin-Derivate, deren Säureadditionssalze, Verfahren zu deren Herstellung und pharmazeutisches Präparat | |
| WO1990012574A1 (en) | Dopamine agonist compounds | |
| Hart et al. | Alkaloids of Alchornea javanensis (Euphorbiaceae): The isolation of hexahydroimidazo [1, 2-a] pyrimidines and guanidines | |
| Takemoto et al. | Studies on the Constituents of Chloranthus spp. I. The Structures of Two New Amides from Chloranthus serratus and the Isolation of Isofraxidin from C. japonicus | |
| DE2330912B2 (de) | Verfahren zur Herstellung von Bromergolinverbindungen | |
| Schwab | 14-(Arylhydroxyamino) codeinones and derivatives as analgetics and antagonists | |
| US3513169A (en) | 5,9-diethyl benzomorphan derivatives | |
| SU867303A3 (ru) | Способ получени производных тетрагидро-1,3,5-триазин-2,6-диона или их основных солей | |
| NZ195329A (en) | 6,7-benzomorphan derivatives and pharmaceutical compositions | |
| US4198514A (en) | Lactam compounds | |
| US2959594A (en) | Iso-benzmorphan derivatives | |
| DE3118521A1 (de) | Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien | |
| Stevens et al. | Rearrangement reactions of hexose 4-0-sulfonates in the presence of azide and phthalimide nucleophiles | |
| Kaneko et al. | A Novel Synthesis of Revenine and Related Alkaloids by Means of a Photo-rearrangement Reaction of 4-Alkoxy-2-methylquinoline 1-Oxides | |
| US3859291A (en) | 9-(p-anisidino)-7-methyl-(1h)-pyrazolo(3,4-f)quinoline | |
| EP0101951A1 (en) | 1,3-Dioxolo(4,5-g)quinolines and preparation thereof | |
| US3459764A (en) | Preparation of nitroimidazole carbamates | |
| US3957785A (en) | Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives | |
| SU1547708A3 (ru) | Способ получени третбутил производного эрголина | |
| DE2354327C3 (de) | 2-Amino-l,23>4-tetrahydronaphthalin-Derivate, Verfahren zu deren Herstellung und Verfahren zur Herstellung von 6,7-Benzomorphanen ausgehend von jenen | |
| DE2229770A1 (de) | N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung | |
| US4174451A (en) | 2-Furyl-(3,4-dimethyl-2-pyridyl)-carbinol |